BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/21/2020 6:42:51 AM | Browse: 990 | Download: 2440
 |
Received |
|
2020-06-03 23:09 |
|
Peer-Review Started |
|
2020-06-03 23:09 |
|
First Decision by Editorial Office Director |
|
2020-06-18 04:36 |
|
Return for Revision |
|
2020-06-18 04:36 |
|
Revised |
|
2020-06-30 21:27 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-07-28 12:14 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-07-30 05:14 |
|
Articles in Press |
|
2020-07-30 05:14 |
|
Edit the Manuscript by Language Editor |
|
2020-08-08 03:21 |
|
Typeset the Manuscript |
|
2020-08-20 00:40 |
|
Publish the Manuscript Online |
|
2020-08-21 06:42 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
his article is an open-access article that was selected by an inhouse editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Bo Xiao, Jun-Yong Weng, Yang-Yang Hu, Gui-Long Deng and Xin-Jian Wan |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81470904 |
| Science and Technology Development Funds of Shanghai of China |
16411952400 |
| National Natural Science Foundation of China |
81870452 |
|
| Corresponding Author |
Xin-Jian Wan, MD, Chief Doctor, Department of Gastroenterology & Shanghai Key Laboratory of Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, No. 650, Xinsongjiang Road, Shanghai 201620, China. xinjian_wan_shsl@163.com |
| Key Words |
Extrahepatic cholangiocarcinoma; Drug-eluting stent; Local chemotherapy; Gemcitabine; Cisplatin; Biliary obstruction |
| Core Tip |
Drug-eluting stent is a relatively new therapeutic concept for malignant biliary obstructions; however, there have only been limited studies reported and all of them were single-drug-loaded type with a simple design, also lack complete, serial in vitro and in vivo study. Our study was the first trial to apply dual chemotherapeutic medications to Drug-eluting stent with several improvements in the design compared to previous ones for the palliative therapy of extrahepatic cholangiocarcinoma with relatively complete pre-clinical evaluation, and our results indicated this brand-new stent could be a promising alternative to realize dual functions of biliary drainage and local chemotherapy. |
| Publish Date |
2020-08-21 06:42 |
| Citation |
Xiao JB, Weng JY, Hu YY, Deng GL, Wan XJ. Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma. World J Gastroenterol 2020; 26(31): 4589-4606 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i31/4589.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i31.4589 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
